FILE PHOTO: Vials of Pfizer's COVID-19 vaccine
KUALA LUMPUR - Malaysia has granted conditional approval for the COVID-19 vaccine made by Pfizer and BioNTech to be used as a booster shot, the health ministry said on Friday. The approval allows the vaccine to be used only on adults aged 18 and above, at least six months after they have received their second dose, the ministry said in a statement.
Authorities earlier said booster shots would not be compulsory but were highly recommended for those in vulnerable and high-risk groups. The mixing of different vaccines will also be allowed for booster doses. In addition to the Pfizer-BioNTech shot, Malaysia uses vaccines made by Britain's AstraZeneca and Chinese firms Sinovac and CanSino Biologics in its national inoculation campaign.This story refiles to correct paragraph 4 RIC of CanSino Biologics.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Japan secures 120 million more Pfizer COVID-19 vaccine doses for next yearTOKYO: Japan has struck a deal with Pfizer Inc to be supplied with another 120 million COVID-19 vaccine doses from January 2022, its health ministry said on Friday (Oct 8). Japan kicked off its inoculation effort in February using imported doses of the shot developed by Pfizer and BioNTech SE.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Pfizer study to vaccinate whole Brazilian town against COVID-19BRASILIA (Reuters) -Pfizer Inc will study the effectiveness of its vaccine against COVID-19 by inoculating the entire population over the age of 12 in a town in southern Brazil, the company said on Wednesday. The study will be conducted in Toledo, population 143,000, in the west of Parana state, together with Brazil's National Vaccination Program, local health authorities, a hospital and a federal university. Pfizer, which developed the vaccine with German partner BioNTech SE, said the purpose was to study transmission of the coronavirus in a 'real-life scenario' after the population has been vaccinated.
Source: YahooSG - 🏆 3. / 71 Read more »
Japan secures 120 million more Pfizer COVID-19 vaccine doses for next yearTOKYO: Japan has struck a deal with Pfizer Inc to be supplied with another 120 million COVID-19 vaccine doses from January 2022, its health ministry said on Friday (Oct 8). Japan kicked off its inoculation effort in February using imported doses of the shot developed by Pfizer and BioNTech SE.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »